---
title: "Supplementary Materials"
subtitle: "Environment-Wide Association Study of Chemical Biomarkers and Health Outcomes in NHANES 2017--2018"
author: Hayden Farquhar
date: February 5, 2026
---

# Table S1. All 26 FDR-Significant Associations from the Discovery Phase

Survey-weighted linear regression of log-transformed chemical biomarker on health outcome, adjusted for age, sex, race/ethnicity, poverty--income ratio, BMI (when not the outcome), and smoking status. 95% CIs calculated as $\beta \pm 1.96 \times \text{SE}$.

| Chemical | Outcome | Class | $\beta$ | 95% CI | SE | P-value | FDR | N |
|:---|:---|:---|---:|:---|---:|:---|:---|---:|
| Blood manganese | RBC count | Heavy metals | 0.23 | (0.19, 0.27) | 0.020 | 9.8e-06 | 0.024 | 4,873 |
| Blood selenium | Hemoglobin | Heavy metals | 2.16 | (1.74, 2.58) | 0.215 | 2.0e-05 | 0.024 | 4,873 |
| Urinary perchlorate | BUN | Urinary elements | 1.21 | (0.97, 1.45) | 0.124 | 2.5e-05 | 0.024 | 1,579 |
| MEOHP (phthalate) | Total bilirubin | Phthalates | -0.06 | (-0.07, -0.05) | 0.006 | 4.0e-05 | 0.024 | 1,580 |
| Methylmercury | Alk Phosphatase | Heavy metals | -2.84 | (-3.47, -2.21) | 0.321 | 4.8e-05 | 0.024 | 4,834 |
| Blood manganese | Waist circumference | Heavy metals | 7.16 | (5.33, 8.99) | 0.934 | 5.9e-05 | 0.024 | 4,693 |
| MEHHP (phthalate) | Total bilirubin | Phthalates | -0.06 | (-0.08, -0.05) | 0.006 | 6.1e-05 | 0.024 | 1,580 |
| Blood selenium | Total cholesterol | Heavy metals | 39.59 | (30.02, 49.15) | 4.880 | 8.3e-05 | 0.029 | 4,855 |
| Blood manganese | BMI | Heavy metals | 2.59 | (1.87, 3.30) | 0.367 | 1.1e-04 | 0.030 | 4,876 |
| Blood lead | Waist circumference | Heavy metals | -4.35 | (-5.58, -3.13) | 0.624 | 1.2e-04 | 0.030 | 4,693 |
| Urinary lead | eGFR | Urinary metals | 6.55 | (5.09, 8.01) | 0.746 | 1.2e-04 | 0.030 | 1,589 |
| Blood lead | BMI | Heavy metals | -1.95 | (-2.51, -1.38) | 0.289 | 1.5e-04 | 0.030 | 4,876 |
| Blood mercury (total) | Alk Phosphatase (log) | Heavy metals | -0.04 | (-0.05, -0.03) | 0.005 | 1.5e-04 | 0.030 | 4,833 |
| DMA (urinary) | Uric acid | Urinary metals | 0.20 | (0.15, 0.26) | 0.027 | 1.5e-04 | 0.030 | 1,593 |
| Urinary cesium | eGFR | Urinary metals | 9.78 | (7.48, 12.08) | 1.174 | 1.6e-04 | 0.030 | 1,589 |
| Glyphosate (serum) | BUN | Surplus serum | 1.22 | (0.89, 1.55) | 0.170 | 1.8e-04 | 0.031 | 1,371 |
| Blood selenium | RBC count | Heavy metals | 0.55 | (0.40, 0.70) | 0.077 | 1.9e-04 | 0.031 | 4,873 |
| Blood lead | Total cholesterol | Heavy metals | 9.10 | (6.55, 11.65) | 1.300 | 2.1e-04 | 0.032 | 4,855 |
| Urinary thallium | eGFR | Urinary metals | 7.68 | (5.78, 9.59) | 0.970 | 2.2e-04 | 0.032 | 1,589 |
| Methylmercury | Waist circumference | Heavy metals | -1.78 | (-2.34, -1.23) | 0.282 | 2.3e-04 | 0.032 | 4,693 |
| Oxychlordane | eGFR | VOC metabolites | 3.23 | (2.39, 4.06) | 0.428 | 2.8e-04 | 0.036 | 1,589 |
| Urinary cadmium | BUN | Urinary metals | -1.02 | (-1.29, -0.76) | 0.137 | 3.0e-04 | 0.036 | 1,589 |
| Glyphosate (serum) | Chloride | Surplus serum | 0.46 | (0.32, 0.59) | 0.069 | 3.0e-04 | 0.036 | 1,374 |
| Blood lead | HbA1c | Heavy metals | -0.19 | (-0.25, -0.13) | 0.029 | 3.4e-04 | 0.039 | 4,874 |
| Urinary cobalt | eGFR | Urinary metals | 3.75 | (2.74, 4.76) | 0.516 | 3.4e-04 | 0.039 | 1,589 |
| Urinary iodine | BMI | Urinary elements | 1.18 | (0.78, 1.58) | 0.205 | 4.4e-04 | 0.047 | 1,600 |

\newpage

# Table S2. Dose--Response Quartile Analysis for 15 Validated Findings

Survey-weighted adjusted mean differences in outcome relative to the lowest exposure quartile (Q1, reference). P~trend~ from linear contrast across quartile midpoints.

| Chemical | Outcome | Q2 $\beta$ | Q3 $\beta$ | Q4 $\beta$ | P~trend~ | Monotonic | N |
|:---|:---|---:|---:|---:|:---|:---:|---:|
| Blood selenium | Hemoglobin | 0.43 | 0.60 | 0.83 | 1.1e-05 | Yes | 4,873 |
| Urinary perchlorate | BUN | 0.71 | 2.07 | 2.66 | 6.3e-05 | Yes | 1,579 |
| Methylmercury | Alk Phosphatase | -2.07 | -4.00 | -7.91 | 1.7e-04 | Yes | 4,834 |
| Blood manganese | Waist circumference | 2.52 | 4.55 | 6.18 | 1.2e-04 | Yes | 4,693 |
| Blood selenium | Total cholesterol | 4.16 | 8.94 | 15.66 | 1.3e-04 | Yes | 4,855 |
| Blood manganese | BMI | 1.15 | 1.74 | 2.25 | 2.0e-04 | Yes | 4,876 |
| Blood lead | Waist circumference | -4.31 | -4.85 | -9.09 | 1.5e-04 | Yes | 4,693 |
| Blood lead | BMI | -1.77 | -2.26 | -4.13 | 1.5e-04 | Yes | 4,876 |
| Blood mercury (total) | Alk Phosphatase (log) | -0.01 | -0.03 | -0.09 | 1.7e-04 | Yes | 4,833 |
| DMA (urinary) | Uric acid | 0.05 | 0.25 | 0.34 | 4.7e-04 | Yes | 1,593 |
| Blood selenium | RBC count | 0.10 | 0.13 | 0.21 | 3.4e-04 | Yes | 4,873 |
| Blood lead | Total cholesterol | 5.16 | 13.00 | 17.33 | 7.7e-05 | Yes | 4,855 |
| Methylmercury | Waist circumference | -1.54 | -2.68 | -5.26 | 3.2e-04 | Yes | 4,693 |
| Blood lead | HbA1c | -0.10 | -0.24 | -0.36 | 2.4e-04 | Yes | 4,874 |
| Urinary iodine | BMI | 2.17 | 1.95 | 2.75 | 4.3e-03 | No | 1,600 |

\newpage

# Table S3. Sensitivity Analysis Summary for 15 Validated Findings

Each finding was tested under 9 specifications: (1) primary model, (2) females only, (3) males only, (4) age < 50, (5) age $\geq$ 50, (6) excluding outliers > 99th percentile, (7) adjusting for education, (8) cotinine instead of binary smoking, and (9) adults aged 20+ only. A finding is "robust" if $\geq$ 7 of 9 specifications show concordant direction and p < 0.05.

| Chemical | Outcome | Dir. Match | Sig. (p<0.05) | Median % $\Delta\beta$ | Robust |
|:---|:---|:---:|:---:|---:|:---:|
| Blood manganese | BMI | 9/9 | 9/9 | 5.8% | Yes |
| Blood manganese | Waist circumference | 9/9 | 9/9 | 4.1% | Yes |
| Blood lead | BMI | 9/9 | 9/9 | 11.6% | Yes |
| Blood lead | Waist circumference | 9/9 | 9/9 | 11.0% | Yes |
| Urinary iodine | BMI | 9/9 | 9/9 | 0.7% | Yes |
| Urinary perchlorate | BUN | 9/9 | 9/9 | 5.5% | Yes |
| Methylmercury | Alk Phosphatase | 9/9 | 8/9 | 3.1% | Yes |
| Blood lead | HbA1c | 9/9 | 8/9 | 10.5% | Yes |
| Blood lead | Total cholesterol | 9/9 | 8/9 | 6.2% | Yes |
| Blood selenium | Hemoglobin | 9/9 | 8/9 | 8.4% | Yes |
| Blood selenium | RBC count | 9/9 | 8/9 | 2.1% | Yes |
| Blood selenium | Total cholesterol | 9/9 | 8/9 | 2.9% | Yes |
| Blood mercury (total) | Alk Phosphatase (log) | 9/9 | 8/9 | 2.8% | Yes |
| DMA (urinary) | Uric acid | 9/9 | 8/9 | 1.4% | Yes |
| Methylmercury | Waist circumference | 9/9 | 7/9 | 13.1% | Yes |

\newpage

# Table S4. Detailed Sensitivity Results for HIGH-Novelty Findings

Effect estimates ($\beta$), standard errors, and p-values for each of the 9 sensitivity specifications for the three HIGH-novelty findings.

## DMA (urinary) -- Uric acid

| Specification | $\beta$ | SE | P-value | N | $\Delta\beta$ (%) |
|:---|---:|---:|:---|---:|---:|
| Primary model | 0.202 | 0.027 | 1.5e-04 | 1,593 | -- |
| Females only | 0.191 | 0.042 | 0.002 | 813 | -5.4 |
| Males only | 0.227 | 0.077 | 0.018 | 780 | +12.4 |
| Age < 50 | 0.204 | 0.055 | 0.008 | 697 | +1.4 |
| Age $\geq$ 50 | 0.179 | 0.084 | 0.070 | 896 | -11.4 |
| Excl. outliers (>P99) | 0.220 | 0.032 | 2.4e-04 | 1,575 | +9.1 |
| Adjust for education | 0.203 | 0.030 | 0.021 | 1,593 | +0.8 |
| Cotinine for smoking | 0.202 | 0.028 | 1.6e-04 | 1,593 | +0.1 |
| Adults 20+ only | 0.202 | 0.027 | 1.5e-04 | 1,593 | -- |

## Urinary perchlorate -- BUN

| Specification | $\beta$ | SE | P-value | N | $\Delta\beta$ (%) |
|:---|---:|---:|:---|---:|---:|
| Primary model | 1.211 | 0.124 | 2.5e-05 | 1,579 | -- |
| Females only | 1.444 | 0.229 | 2.3e-04 | 803 | +19.3 |
| Males only | 0.870 | 0.233 | 0.006 | 776 | -28.1 |
| Age < 50 | 0.965 | 0.161 | 5.4e-04 | 692 | -20.3 |
| Age $\geq$ 50 | 1.382 | 0.238 | 6.6e-04 | 887 | +14.2 |
| Excl. outliers (>P99) | 1.277 | 0.134 | 3.0e-05 | 1,563 | +5.5 |
| Adjust for education | 1.209 | 0.122 | 0.002 | 1,579 | -0.1 |
| Cotinine for smoking | 1.210 | 0.128 | 3.0e-05 | 1,579 | 0.0 |
| Adults 20+ only | 1.211 | 0.124 | 2.5e-05 | 1,579 | -- |

## Methylmercury -- Waist circumference

| Specification | $\beta$ | SE | P-value | N | $\Delta\beta$ (%) |
|:---|---:|---:|:---|---:|---:|
| Primary model | -1.783 | 0.282 | 2.3e-04 | 4,693 | -- |
| Females only | -2.868 | 0.556 | 5.9e-04 | 2,413 | +60.9 |
| Males only | -0.909 | 0.403 | 0.050 | 2,280 | -49.0 |
| Age < 50 | -2.474 | 0.458 | 6.5e-04 | 2,121 | +38.8 |
| Age $\geq$ 50 | -1.166 | 0.551 | 0.067 | 2,572 | -34.6 |
| Excl. outliers (>P99) | -1.886 | 0.297 | 2.2e-04 | 4,643 | +5.8 |
| Adjust for education | -1.549 | 0.330 | 0.042 | 4,693 | -13.1 |
| Cotinine for smoking | -1.788 | 0.284 | 2.3e-04 | 4,693 | +0.3 |
| Adults 20+ only | -1.783 | 0.282 | 2.3e-04 | 4,693 | -- |

\newpage

# Table S5. Additional Sensitivity Analyses

Four additional sensitivity specifications were applied to assess specific confounding concerns. Fish consumption (DBD895, number of fish/shellfish meals in 30 days) and physical activity (PAQ_J) were tested for all 15 validated findings. Alcohol consumption (ALQ_J) could not be assessed due to extensive missing data from NHANES skip patterns. Urinary creatinine adjustment (log-transformed) was applied to the three urinary biomarker associations to address dilution variation.

## Fish consumption and physical activity adjustment

Adjustment for fish consumption did not materially change any of the 15 validated findings (all $|\Delta\beta|$ < 1%). Physical activity adjustment likewise produced no change ($|\Delta\beta|$ < 0.01% for all findings). These results are consistent across all 15 associations and indicate that the primary findings are not confounded by fish intake frequency or recreational physical activity level.

## Urinary creatinine adjustment

| Chemical | Outcome | $\beta$ (primary) | $\beta$ (creatinine-adj) | $\Delta\beta$ (%) | P (creatinine-adj) | Interpretation |
|:---|:---|---:|---:|---:|:---|:---|
| Urinary perchlorate | BUN | 1.211 | 1.217 | +0.5% | 0.001 | Robust; not driven by dilution |
| DMA (urinary) | Uric acid | 0.202 | 0.135 | -32.9% | 0.012 | Attenuated but significant; partial dilution contribution |
| Urinary iodine | BMI | 1.177 | 0.402 | -65.9% | 0.153 | **Eliminated**; probable dilution artifact |

The perchlorate--BUN association was unchanged by creatinine adjustment, confirming that urinary dilution variation does not explain this signal. The DMA--uric acid association was attenuated by approximately one-third but remained statistically significant, suggesting that urinary concentration contributes to but does not fully account for the observed relationship. The urinary iodine--BMI association was eliminated after creatinine correction, indicating that the original signal reflected systematic differences in urine concentration correlated with body size rather than genuine iodine exposure effects.

\newpage

# Figures S1--S15. Individual Sensitivity Forest Plots

Forest plots showing the effect estimate ($\beta$) and 95% confidence interval for each of the 9 sensitivity specifications. The vertical dashed line marks $\beta$ = 0 (null). Findings are ordered by novelty tier.

## HIGH Novelty

![Figure S1. Sensitivity analysis: DMA (urinary) -- Uric acid.](figures/fig5_sensitivity_Dimethylarsonic_acid__urinary_____Uric_acid.png)

![Figure S2. Sensitivity analysis: Urinary perchlorate -- BUN.](figures/fig5_sensitivity_Urinary_perchlorate____BUN.png)

![Figure S3. Sensitivity analysis: Methylmercury -- Waist circumference.](figures/fig5_sensitivity_Methylmercury__blood_____Waist_circumference.png)

\newpage

## MODERATE Novelty

![Figure S4. Sensitivity analysis: Methylmercury -- Alkaline Phosphatase.](figures/fig5_sensitivity_Methylmercury__blood_____Alk_Phosphatase.png)

![Figure S5. Sensitivity analysis: Blood manganese -- BMI.](figures/fig5_sensitivity_Blood_manganese____BMI.png)

![Figure S6. Sensitivity analysis: Blood manganese -- Waist circumference.](figures/fig5_sensitivity_Blood_manganese____Waist_circumference.png)

![Figure S7. Sensitivity analysis: Blood mercury (total) -- Alkaline Phosphatase (log).](figures/fig5_sensitivity_Blood_mercury__total_____Alk_Phosphatase__log_.png)

![Figure S8. Sensitivity analysis: Urinary iodine -- BMI.](figures/fig5_sensitivity_Urinary_iodine____BMI.png)

\newpage

## LOW-MODERATE Novelty

![Figure S9. Sensitivity analysis: Blood selenium -- Hemoglobin.](figures/fig5_sensitivity_Blood_selenium____Hemoglobin.png)

![Figure S10. Sensitivity analysis: Blood selenium -- RBC count.](figures/fig5_sensitivity_Blood_selenium____RBC_count.png)

\newpage

## LOW Novelty

![Figure S11. Sensitivity analysis: Blood lead -- BMI.](figures/fig5_sensitivity_Blood_lead____BMI.png)

![Figure S12. Sensitivity analysis: Blood lead -- Waist circumference.](figures/fig5_sensitivity_Blood_lead____Waist_circumference.png)

![Figure S13. Sensitivity analysis: Blood lead -- HbA1c.](figures/fig5_sensitivity_Blood_lead____HbA1c.png)

![Figure S14. Sensitivity analysis: Blood lead -- Total cholesterol.](figures/fig5_sensitivity_Blood_lead____Total_cholesterol.png)

![Figure S15. Sensitivity analysis: Blood selenium -- Total cholesterol.](figures/fig5_sensitivity_Blood_selenium____Total_cholesterol.png)
